Cellyan Biotechnology/$HKPD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cellyan Biotechnology
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
Ticker
$HKPD
Sector
Mobility
Primary listing
Employees
27
Headquarters
Yau Tong, Hong Kong
Website
HKPD Metrics
BasicAdvanced
$7M
-
-$0.07
-
-
Price and volume
Market cap
$7M
52-week high
$2.76
52-week low
$0.58
Average daily volume
41K
Financial strength
Current ratio
2.927
Quick ratio
2.731
Long term debt to equity
28.469
Total debt to equity
44.186
Interest coverage (TTM)
-5.41%
Profitability
EBITDA (TTM)
-0.513
Gross margin (TTM)
8.80%
Net profit margin (TTM)
-4.29%
Operating margin (TTM)
-3.68%
Effective tax rate (TTM)
8.96%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
-3.80%
Return on equity (TTM)
-13.37%
Valuation
Price to revenue (TTM)
0.416
Price to book
1.36
Price to tangible book (TTM)
1.38
Price to free cash flow (TTM)
-13.097
Free cash flow yield (TTM)
-7.64%
Free cash flow per share (TTM)
-0.048
Growth
Revenue change (TTM)
-21.23%
Earnings per share change (TTM)
-130.92%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cellyan Biotechnology stock?
Cellyan Biotechnology (HKPD) has a market cap of $7M as of March 21, 2026.
What is the P/E ratio for Cellyan Biotechnology stock?
The price to earnings (P/E) ratio for Cellyan Biotechnology (HKPD) stock is 0 as of March 21, 2026.
Does Cellyan Biotechnology stock pay dividends?
No, Cellyan Biotechnology (HKPD) stock does not pay dividends to its shareholders as of March 21, 2026.
When is the next Cellyan Biotechnology dividend payment date?
Cellyan Biotechnology (HKPD) stock does not pay dividends to its shareholders.
What is the beta indicator for Cellyan Biotechnology?
Cellyan Biotechnology (HKPD) does not currently have a Beta indicator.